Navigation Links
Sea snail saliva may become new treatment for most severe pain
Date:7/28/2010

Scientists have developed a new version of a medication, first isolated from the saliva of sea snails, that could be taken in pill form to relieve the most severe forms of pain as effectively as morphine but without risking addiction. An article on the topic appears in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.

C&EN Senior Editor Bethany Halford notes that a sea snails' saliva contains chemicals that help the slow-moving creatures catch prey. They include chemicals that the snails inject into passing prey with hypodermic-needle-like teeth that shoot from their mouths like harpoons. Scientists already have transformed one of these chemicals into a pain-reliever for humans, but it has to be injected directly into the spinal cord, limiting its use.

Now scientists in Australia have developed a form of the painkiller that can be given by mouth. It relieves severe pain, such as that in people with peripheral neuropathy, at a much lower dose than existing medications and without the risk of causing addiction. The article quotes one expert as speculating that such a drug could revolutionize the treatment of the most severe forms of pain.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. Can you make a snail forget?
2. Presence of snails points to forest recovery
3. The fantastic armor of a wonder snail
4. National assessment done on potential invasive snail and slug pests in US
5. Penn biologists demonstrate that size matters... in snail shells
6. Snails and humans use same genes to tell right from left
7. UH Manoa researchers release results of statewide survey of snail, slug invasions in Hawaii
8. Ripple effect: Water snails offer new propulsion possibilities
9. First preliminary profile of proteins in bed bugs saliva
10. Answer to saliva mystery has practical impact
11. Solution to beading-saliva mystery has practical purposes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2016)... FREMONT, Calif. , Dec. 15, 2016   ... a publicly held genomics technology company, announced today that ... the Listing Qualifications Department of The Nasdaq Stock Market ... the closing bid price of WaferGen,s common stock had ... days.  Accordingly, WaferGen has regained compliance with Listing Rule ...
(Date:12/15/2016)... , Dec. 15, 2016  There is much more ... or starting the engine. Continental will demonstrate the intelligence ... Las Vegas . Through the combination of the ... Entry) and biometric elements, the international technology company is ... personalization and authentication. "The integration of biometric ...
(Date:12/8/2016)... PUNE, India , Dec. 8, 2016 Market Research ... and Service Market. The global Mobile Biometric Security and Service Market ... period 2016 to 2022. Market Highlights: ... , , ... fast pace due to the increasing need of authentication and security ...
Breaking Biology News(10 mins):
(Date:1/23/2017)... N.J. , Jan. 23, 2017   Enteris ... feasibility study agreement with Sanofi to leverage ... delivery platform, Peptelligenceā„¢, to develop an oral formulation of ... Joel Tune , Chief Executive Officer and Executive ... is further validation of the tremendous value our Peptelligence ...
(Date:1/23/2017)... 2017  Alkahest Inc. ("Alkahest"), a biotechnology company ... and other age-related conditions, announced today that Sam Jackson, ... Medical Officer. In this role, Dr. Jackson will ... Alkahest and serve on the Executive Leadership Team.  ... Executive Director at Dynavax, where he led the Drug ...
(Date:1/21/2017)... ... ... Nipro Corporation (Osaka, Japan) and Transonic Systems Inc. (New York, USA) announced the ... sales rights for all non-OEM Transonic products in Japan. As partners for more than ... - Transonic JV is a natural next step to advance best practices and further ...
(Date:1/21/2017)... , Jan. 20, 2017 Aratana Therapeutics, ... company focused on the licensing, development and commercialization of ... Pharm,s Best Company in North America ... the award based on the FDA approval ... (grapiprant tablets), ENTYCE Ā® (capromorelin oral solution) and ...
Breaking Biology Technology: